Maintenance therapy for first-line metastatic colorectal cancer: activity and sustainability.

Journal Article (Journal Article)

Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.

Full Text

Duke Authors

Cited Authors

  • Strickler, JH; Hurwitz, HI

Published Date

  • 2012

Published In

Volume / Issue

  • 17 / 1

Start / End Page

  • 9 - 10

PubMed ID

  • 22234629

Pubmed Central ID

  • PMC3267828

Electronic International Standard Serial Number (EISSN)

  • 1549-490X

Digital Object Identifier (DOI)

  • 10.1634/theoncologist.2011-0358


  • eng

Conference Location

  • England